KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average (2016 - 2025)

Medpace Holdings' Equity Average history spans 10 years, with the latest figure at $376.4 million for Q4 2025.

  • For Q4 2025, Equity Average fell 55.9% year-over-year to $376.4 million; the TTM value through Dec 2025 reached $376.4 million, down 55.9%, while the annual FY2025 figure was $642.3 million, 7.21% down from the prior year.
  • Equity Average reached $376.4 million in Q4 2025 per MEDP's latest filing, up from $233.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $925.5 million in Q4 2021 to a low of $233.0 million in Q3 2025.
  • Average Equity Average over 5 years is $589.4 million, with a median of $565.1 million recorded in 2023.
  • Peak YoY movement for Equity Average: surged 94.38% in 2024, then plummeted 71.67% in 2025.
  • A 5-year view of Equity Average shows it stood at $925.5 million in 2021, then tumbled by 60.22% to $368.1 million in 2022, then surged by 39.88% to $514.9 million in 2023, then soared by 65.75% to $853.5 million in 2024, then tumbled by 55.9% to $376.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Equity Average are $376.4 million (Q4 2025), $233.0 million (Q3 2025), and $383.0 million (Q2 2025).